Literature DB >> 16775181

A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.

Katherine A McGlynn1, Robert E Tarone, Hashem B El-Serag.   

Abstract

The incidence rates of liver cancers, both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), are increasing in the U.S. It is possible that the increases are related to common exposures, and if so, similar trends in incidence by gender, age, ethnicity, and calendar period, might exist. To examine this hypothesis, age-specific trends in the incidence of HCC and ICC in the Surveillance, Epidemiology and End Results program (1976-2000) were examined by year of diagnosis and year of birth. Age-period-cohort models were also fit to the data. The incidence of HCC in the most recent time period was twice as high among Black men (8.8/100,000) and women (2.6/100,000) as among White men (4.6/100,000) and women (1.2/100,000). However, between 1976 and 2000, incidence among all four ethnic- and gender-specific groups increased by >90% (White males, 123.2%; White females, 96.8%; Black males, 97.9%; Black females, 91.9%) with young White men experiencing the greatest increases (432%). In contrast, ICC rates were similar for Black (0.93/100,000) and White men (0.92/100,000), but higher for White (0.57/100,000) than Black women (0.39/100,000). Although ICC incidence increased among all groups, the increase was greatest for Black men (138.5%), followed by White men (124.4%), White women (111.1%), and Black women (85.7%) Age-period-cohort analyses of HCC revealed a significant cohort effect among younger men (45-65 years old), but not older men (65-84 years old), suggesting possible differences in etiology. In conclusion, the rates of HCC and ICC approximately doubled between 1976 and 2000. Trends by age, gender, ethnicity, and birth cohort suggest that heterogeneity exists in the factors influencing these rates.

Entities:  

Mesh:

Year:  2006        PMID: 16775181     DOI: 10.1158/1055-9965.EPI-05-0811

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  67 in total

1.  Socioeconomic status and hepatocellular carcinoma in the United States.

Authors:  Fatma M Shebl; David E Capo-Ramos; Barry I Graubard; Katherine A McGlynn; Sean F Altekruse
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-05       Impact factor: 4.254

2.  Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.

Authors:  Sarah B Fisher; Sameer H Patel; David A Kooby; Sharon Weber; Mark Bloomston; Clifford Cho; Ioannis Hatzaras; Carl Schmidt; Emily Winslow; Charles A Staley; Shishir K Maithel
Journal:  HPB (Oxford)       Date:  2012-05-22       Impact factor: 3.647

3.  Primary liver cancer: intrahepatic cholangiocarcinoma emerges from the shadows.

Authors:  Susan Tsai; Hari Nathan; Timothy M Pawlik
Journal:  Updates Surg       Date:  2010-08

4.  Accomplishments in 2007 in the management of hepatobiliary cancers.

Authors:  Anthony T C Chan; Yoji Kishi; Stephen L Chan; Jean-Nicolas Vauthey
Journal:  Gastrointest Cancer Res       Date:  2008-05

5.  Liver cancer mortality among male prison inmates in Texas, 1992-2003.

Authors:  Amy J Harzke; Jacques G Baillargeon; Karen J Goodman; Sandi L Pruitt
Journal:  Prev Med       Date:  2009-03-13       Impact factor: 4.018

6.  Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.

Authors:  Christopher J Hoffmann; Aruna K Subramanian; Andrew M Cameron; Eric A Engels
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

7.  Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.

Authors:  Alphonse E Sirica; Michael H Nathanson; Gregory J Gores; Nicholas F Larusso
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

8.  Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea.

Authors:  Hai-Rim Shin; Jin-Kyoung Oh; Min Kyung Lim; Aesun Shin; Hyun-Joo Kong; Kyu-Won Jung; Young-Joo Won; Sohee Park; Sang-Jae Park; Sung-Tae Hong
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

9.  Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Somsak Likhitrattanapisal; Jaitip Tipanee; Tavan Janvilisri
Journal:  Tumour Biol       Date:  2016-07-22

10.  Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.

Authors:  Robert J Wong; Douglas A Corley
Journal:  Dig Dis Sci       Date:  2009-01-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.